Questionnaire Survey of the Telepharmacy Demonstration Project at the National Strategic Special Zone in Yabu City (Hyogo) and Fukuoka City

DOI Web Site 2 Citations 2 References Open Access
  • Inukai Moeno
    Laboratory of Clinical Pharmacology and Therapeutics, Graduate School and School of Pharmaceutical Sciences, Osaka University
  • Yokoyama Toshiyuki
    Mitsui & Co., Ltd.
  • Daimon Rikio
    Mitsui & Co., Ltd.
  • Matsuura Nobufumi
    Mitsui & Co., Ltd.
  • Tanaka Ryota
    Mitsui & Co., Ltd.
  • Hirobe Sachiko
    Laboratory of Clinical Pharmacology and Therapeutics, Graduate School and School of Pharmaceutical Sciences, Osaka University Department of Pharmacy, Osaka University Hospital Department of Molecular Pharmaceutical Science, Graduate School of Medicine, Osaka University

Bibliographic Information

Other Title
  • 兵庫県養父市および福岡市の国家戦略特区におけるオンライン服薬指導実証事業実施に関するアンケート調査

Search this article

Description

<p>To cope with the aging population of Japan, medical care needs to be more accessible and efficient. Furthermore, resulting from the measures put in place against COVID-19, the use of information and communication technology (ICT) is expected to be promoted; telemedicine and telepharmacy need to be improved and extended to meet the new demands. To evaluate the implementation of telepharmacy and explore the future agenda, we conducted questionnaire surveys of 5 patients, 5 pharmacists from 4 pharmacies, and 3 physicians who participated in the demonstration project in the National Strategic Special Zone. The survey results confirmed that the quality of medication instruction improved, helping patients to be more relaxed at home; pharmacists were able to check the remaining medicines and medication-storage conditions. Although the introduction of telepharmacy required time and effort from pharmacists, telepharmacy facilitated making appointments, allowing for advance arrangements for medication shortage, and better preparation of medication instructions. Both patients and physicians rated telepharmacy highly, especially for the reduction in travel time and enabling comfortable, private conversation in the absence of other patients. It is suggested that telepharmacy may be an appropriate complement to in-person medication instruction for patients with stable chronic diseases, and it is expected to play an important role in the future, including supporting measures against COVID-19.</p>

Journal

Citations (2)*help

See more

References(2)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top